Professional Documents
Culture Documents
IMMUNOLOGY : study of cells, tissues and organs responsible for the recognition and disposal of non-self antigens
HISTORICAL PERSPECTIVE
Individuals who recovered from certain infectious diseases were thereafter protected from the disease
430 BC : Thucydides : after a plague in Athens he wrote that only those who had recovered could nurse the sick
because they would not contract the disease a second time
15th century : Chinese and Turks : dried crusts from smallpox pustules were either inhaled or inserted into
small cuts in the skin (VARIOLATION)
1718 : Lady Mary Montagu ; variolation of her own children
1798 : Edward Jenner : cross-immunity using cowpox to protect against smallpox
Christopher Columbus
Louis Pasteur : hypothesized and proved that aging had weakened the virulence of the pathogen hence may be
used to protect against the disease
Vaccine – attenuated strain
1885 : administered 1st vaccine to a human boy (rabies vaccine)
1890 : Emil von Behring and Shibasaburo Kitasato : mechanism of immunity : demonstrated that serum from
animals previously immunized against diphtheria could transfer the immune state to unimmunized animals
1901 : Emil von Behring received the Nobel Prize for his discovery of serum antitoxins
1902: Portier and Richet: immediate hypersensitivity reaction
1905 : Robert Koch received the Nobel Prize for his discovery of cellular immunity in TB
1930 : Elvin Kabat : immunoglobulin called antibodies contained in body fluids are protective agents (HMI)
1883 : Elie Metchnikoff : certain WBC (phagocytes) were able to ingest microorganisms and foreign material (CMI)
1908 : Elie Metchnikoff received the Nobel Prize for his discovery of phagocytosis
Paul Ehrlich received the Nobel Prize for his studies on immunity
1913 : Charles Richet received the Nobel Prize for his studies on anaphylaxis
1919 : Jules Bordet received the Nobel Prize for his discovery of the complement cascade
1930 : Karl Landsteiner received the Nobel Prize for his discovery of the human blood group antigens (ABO)
1949: Salk and Sabin: polio vaccine
1950 : lymphocyte : cell responsible for both HMI and CMI
1951: Reed: yellow fever vaccine
1960 : Macfarlane Burnet and Peter Medawar received the Nobel Prize for their discovery of immunologic
tolerance
1972 : Gerald Edelman and Rodney Porter received the Nobel Prize for their discovery of the antibody
structure
1977 : Rosalyn Yallow received the Nobel Prize for developing the radioimmunoassay (RIA) technique
1980 : George Snell, Jean Dausset, Baruj Benaceraf received the Nobel Prize for their discovery of the major
histocompatibility complex (MHC)
1984 : Niels Jerne received the Nobel Prize for his discovery of immunoregulation
Georges Koehler, Cesar Milstein received the Nobel Prize for developing monoclonal antibody production
technique
1984 : year of discovery of the T cell receptor gene
1987 : Susumu Tonegawa received the Nobel Prize for his discovery of antibody diversity
Frazer: human papilloma virus
Bruce Glick : CMI : T lymphocytes (thymus derived) and HMI : B lymphocytes (Bursa of Fabricius)
1991 : Edward Donnall Thomas, Joseph Murray received the Nobel Prize for their study on transplantation
1996 : Peter Doherty, Rolf Zinkernagel received the Nobel Prize for their study on cytotoxic T cell recognition of
virally infected cells
2008 : Françoise Barré-Sinoussi, Luc Montagnier received the Nobel Prize for their discovery of the human
immunodeficiency virus (HIV)
INNATE IMMUNITY
External Defense System
Unbroken Skin and Mucous Membranes
Major anatomic and physical barrier
Several secretions present discourages the growth of microorganisms
Mucous secretion
Lysozyme
Normal flora keeps pathogens from establishing themselves
Low pH
Special surface structures
IFN-β
Type 2: IFN-γ
Beta-lysin
TNF-β
PHAGOCYTOSIS
1. Initiation : phagocytosis is initiated as a result of tissue damage
results to increased surface adherence receptors
CR3,
Laminin receptor
N-formyl-methionyl-leucylphenylalanine receptor
Opsonins
Complement factors (C3b, C4b, C5b)
Antibodies (IgG1 and IgA)
Acute Phase Reactants
4. Engulfment :
facilitated by opsonization : coating of foreign entity with plasma factors
phagosome formation
5. Digestion:
Mechanisms in Antigen Destruction
A. Oxygen-Dependent Mechanism
involves increase in oxygen consumption and stimulation of the Hexose
Monophosphate Shunt
generation of bactericidal metabolites
B. Oxygen-Independent Mechanism
Production of nitric oxide
Phagolysosome formation
INFLAMMATION
Tissue damage and infection induce leakage of vascular fluid, containing serum proteins with
antibacterial activity, and influx of phagocytic cells into the affected area
Cardinal signs
1. Rubor: increased blood flow to the area
2. Tumor: leakage of blood plasma to surrounding tissues
3. Calor: IL 1 secreted by mononuclear phagocytes
4. Dolor: lactic acid production by phagocytes
5. Functio laesa : loss of function
CELLULAR RESPONSE
1. Influx of phagocytes
Neutrophils
First to migrate within 30 to 60 minutes and emigration lasts from 24 to 48 hours
Monocytes/Macrophages
Second to migrate within 4 hours and peaks at 16 to 48 hours
Secrete soluble substances
Humoral Response
NAME LOCATION
Lungs
Connective Tissues
Liver
Kidneys
Brain
Bone
Spleen
Placenta
Synovium
Blood
Skin
Lymph Nodes
C. INFLAMMATORY CELLS
1. Basophils
less than 1% of circulating WBCs
10-15 um
contain granules that induce and maintain immediate hypersensitivity reactions
2. Eosinophils
constitutes 1 to 3 % of circulating WBCs
12-15 um in diameter with bilobed or ellipsoidal nucleus
neutralizes basophil and mast cell products and killing certain parasites
3. Mast Cells
connective tissue cells of mesenchymal origin
larger than basophils and contain more granules
life span is between 9 to 18 months
plays a role in hypersensitivity reactions
COMPLEMENT
Major Functions
1. OPSONIZATION
Coating of pathogenic organisms or immune complexes prior to phagocytosis
2. INFLAMMATION
Induction of histamine release from mast cells and basophils
3. CYTOLYTIC FUNCTION
Membrane attack of target cells leading to cell lysis/death
Lupus-like syndrome
C2 Recurrent infections
Atherosclerosis
Severe recurrent infections
C3
Glomerulonephritis
C4 Lupus-like syndrome
C5-C8 Neisseria infections
C9 No known disease association
C1INH Hereditary angioedema
DAF
Paroxysmal nocturnal hemoglobinuria
MIRL/CD59
Factor H or Factor I Recurrent pyogenic infections
Pneumococcal diseases
MBL Sepsis
Neisseria infections
Properdin Neisseria infections
MASP-2 Pneumococcal diseases
ADAPTIVE IMMUNITY
Characteristics of Adaptive Immunity
1. Antigenic specificity – can distinguish between 2 protein molecules that differ in only a single amino acid
2. Diversity – capable of recognizing a wide variety of antigens
3. Immunologic memory – second encounter with the same antigen induces a heightened immune response
4. Self/non-self recognition – capable of distinguishing self from non-self antigens
LYMPHOID ORGANS
TWO MAIN GROUPS:
1. Primary Lymphoid Organs
Provide appropriate microenvironments for the development and maturation of lymphocytes
Releases mature lymphocytes
Thymus and bone marrow
2. Secondary Lymphoid Organs
Trap antigen from defined tissues or vascular spaces and are sites where mature lymphocytes
can interact effectively with the antigen
Site for antigen-dependent lymphopoiesis
Lymph nodes, spleen, MALT : GALT
THYMUS
Site of T-cell development and maturation
Flat bilobed organ situated above the heart
Each lobe is surrounded by a capsule and divided into lobules
Each lobule is composed of the following areas/regions:
1. Outer cortex : densely packed with immature T cells : thymocytes
2. Inner medulla : sparsely populated with thymocytes
Progenitor T cells appear as early as 8 weeks of gestation
Thymocytes Cortex Medulla Mature T cells are released
LYMPH NODES
Small solid structures found at varying points along the lymphatic system
2-10mm in size, spherical and possess an enveloping capsule
Filters lymph and then produces an immune response against any microbe they trap
Divided into 3 parts or areas:
1. Outer Cortex
Contains macrophages
Primary Follicles
Mature, resting B cells
Follicular Dendritic cells
Secondary Follicles
Contains Ag-stimulated proliferating B cells
Plasma cells: produce and secrete antibodies
Memory B cells
2. Paracortex
Region between follicles and medulla
Contains T lymphocytes in close proximity to interdigitating cells
3. Medulla
Less densely populated with T cells and B cells
Contains macrophages and numerous plasma cells
Transit time through a lymph node: 18 hours
In the presence of Ag contact lymphocyte traffic shuts down
Four related but distinct cell membrane molecules are responsible for antigen recognition by the immune system:
1. Membrane-bound antibodies on B cells
2. T-cell receptors
3. CD8 Receptor for Class I MHC molecules
4. CD4 Receptor for Class II MHC molecules
1. DOUBLE-NEGATIVE STAGE
Lacks CD4 and CD8 surface markers
Thymic stromal cells: epithelial cells, macrophages, fibroblasts and dendritic cells
IL 7: for growth and differentiation
Rearrangement of genes coding for Ag receptor
Antigen receptor: T CELL RECEPTOR (TCR)
CD3
8 chains common to all T cells
2 chains responsible for variability
Rearrangement of beta chains occurs first
Beta chain signal: triggers thymocytes to express surface markers
**Other thymocytes: express gamma and delta
become T cell population in skin, intestinal epithelium and pulmonary epithelium
Additional Markers: CD2, CD5 and CD7
2. DOUBLE-POSITIVE STAGE
Thymocytes have CD4 and CD8 markers
Begin rearrangement for alpha chains
Complete TCR expressed on the surface
SELECTION PROCESS:
POSITIVE SELECTION
(+) functional TCR to survive
(+) ability to recognize foreign antigens in association with MHC I and II
**inability to recognize self-MHC presented antigens DEATH
NEGATIVE SELECTION
(-) strong reactions with self-antigens
**ability to react with self-antigens APOPTOSIS
3. SINGLE-POSITIVE STAGE
T cells exhibit either CD4 or CD8 surface marker
NEGATIVE SELECTION: if cells are reactive to self-antigens DEATH
CD4 cells: recognize antigens presented via MHC II
T helper cells (Th)
A. Th 1: intracellular pathogens cytotoxic T cell activation
produce interferon gamma and tumor necrosis factor beta
B. Th 2: extracellular pathogens B cell activation
produce interleukins (IL 4, IL 5, IL 10 and IL 13)
T regulatory cells (Treg)
Contains CD4 and CD25 surface markers
Produces IL 10 and transforming growth factor B
Suppress immune response to self-anitgens
CD8 cells: recognize antigens presented via MHC I
4. ACTIVATED T CELL
Requires interaction with an antigen
Antigen interaction T cells transform and express IL 2 receptors
T lymphoblasts differentiate to active lymphocytes
Effector cells: cytotoxic T cells (Tc)
Memory T cells: persist for years and produce a broader array of cytokines
Cell-mediated immunity starts:
Commencement of Ab production by B cells
Killing of tumor or other target cells
Rejecting grafts
Stimulation of hematopoiesis
Initiation of delayed hypersensitivity reaction
B LYMPHOCYTES
EAC Rosette Assay
B CELL ONTOGENY
B cells remain in the microenvironments provided by bone marrow stromal cells
GROWTH FACTORS: E2A, Early B cell Factor (EBF), Paired Box Protein 5 (PAX)
CYTOKINE: Interleukin 7 (IL 7)
1. PRO-B CELLS
Rearrangement of genes on chromosome 14
3. IMMATURE B CELLS
Appearance of complete IgM molecules on the surface
Rearrangement of genes for light chains
Completion of light chain rearrangement
Mu chains in the cytoplasm are no longer detectable
Surface Markers: CD21, CD40, MHC Class II
4. MATURE B CELLS
Marginal Zone B cells: remain in the spleen to provide a quick response to blood-borne pathogens
Follicular B cells: found in lymph nodes and other tissues
5. ACTIVATED B CELLS
Activation Site: primary follicles of lymphoid tissues and organs
Expression of CD25
Activating Receptors
diseased and cancerous cells lose the ability to produce MHC proteins
CD94/NKG2B and CD94/NKG2C
MICA and MICB: proteins expressed by stressed cells
Two Substances for Destruction
Perforins: pore-forming substance that acts on abnormal cells in the presence of
calcium
Granzymes: packets of serine esterases that mediate cell lysis
2. Ab-DEPENDENT CYTOTOXICITY
NK cells recognize and lyse Ab-coated cells
CD 16: receptor for the Fc portion on IgG
ANTIGENICITY
Ability to combine specifically with the final products of humoral and/or cell-mediated immune response
Complete antigen: carrier + hapten
Incomplete antigen: hapten only
2. MOLECULAR SIZE
The larger the size, the more immunogenic.
Potent antigen: MW greater than 10000 Daltons
Good immunogen: MW greater than 40000 Daltons
Excellent immunogen: MW greater than 1000000 Daltons
B. BIOLOGICAL SYSTEM
1. GENOTYPE
Difference in the response due to genetic variability among individuals
3. ADJUVANTS
Substances that enhance immunogenicity
Examples
Complete Freund’s Adjuvant (CFA)
water in oil emulsion (Mycobacterium butyricum, Bordetella pertussis,
Mycobacterium tuberculosis)
Lipopolysaccharide (LPS)
Alum adjuvant
Squalene (MF59)
Effects
Antigen persistence is prolonged
Co-stimulatory signals are enhanced
Local inflammation is increased
Non-specific proliferation of lymphocytes is stimulated
EPITOPES
Immunologically active regions of an immunogen that bind to antigen-specific membrane receptors on
lymphocytes or to secreted antibodies
B and T cells recognize different epitopes on the same antigenic molecule
HAPTENS
Small organic molecules that are antigen but not immunogenic
Needs a carrier to become accessible to the immune system
IMPORTANCE OF MHC/HLA
1. Disease Association/Susceptibility
Autoimmune disorders, certain viral diseases, disorders of the complement system, some neurologic disorders
and several different allergies
Ankylosing spondylitis : B27
Goodpasture’s syndrome : DR2
Type 1 DM : DR4/DR3
Multiple sclerosis : DR2
SLE : DR3
2. Tissue/Organ Transplant
Siblings: 50%
Parents: 25%
3. Paternity Testing
ANTIBODIES
• Glycoproteins present in serum
• Gamma globulins produced by plasma cells
OTHER TERMS
• ISOTYPE: HC that determines Ig class
• ALLOTYPE: variation in constant region of HC and LC
• IDIOTYPE: variation in the variable region of HC and LC
STRUCTURE OF Ig CLASSES
• MONOMER
IgG, IgD, IgE, most serum IgA
• DIMER
Secretory IgA
• POLYMER
Serum IgM
PROPERTIES OF IMMUNOGLOBULINS
IMMUNOGLOBULIN GAMMA
predominant Ig in humans
4 subclasses: IgG1, 2, 3, 4
provide immunity to NB except IgG2
Complement fixation except IgG4
Best precipitin
IMMUNOGLOBULIN MU
Most primitive
Best agglutinin
Complement fixation
IMMUNOGLOBULIN ALPHA
IgA1: serum
IgA2: secretions
J chain
Secretory piece/component
For mucosal immunity
Prevents attachment of pathogen
IMMUNOGLOBULIN DELTA
Unstimulated, immunocompetent B cells
Immunoregulation
anti-idiotypic Ab
IMMUNOGLOBULIN EPSILON
Heat-labile originally called REAGIN
High affinity for basophils and mast cells
Recognition of parasites
RIST
RAST
2. Instructional theory
1930(Breinl and Haurowitz) -1940 (Pauling)
Antigen : determines the specificity of the antibody molecule
Antibody molecule would then assume a configuration complementary to that of the antigen template
Antigen will serve as the template around which antibody would fold
3. Clonal Selection Theory
1950 : Jerne, Talmadge and Burnet
Individual lymphocyte expresses membrane receptors that are specific for a distinct antigen
Unique receptor specificity is determined before the lymphocyte is exposed to the antigen
Binding of antigen to specific receptor activates it to proliferate into a clone of cells with the same
immunologic specificity as the parent cell
HYPERSENSITIVITY